Literature DB >> 11742486

Factors affecting the survival of patients with oesophageal carcinoma under radiotherapy in the north of Iran.

K O Hajian-Tilaki1.   

Abstract

Factors relevant to the survival of patients with oesophageal cancer under radiotherapy have been studied in northern Iran where its incidence is high. We conducted an analytical study using a historical cohort and information from the medical charts of patients with oesophageal cancer. Out of 523 patients referred to the Shahid Rajaii radiotherapy centre in Babolsar from 1992 to 1996, we followed 230 patients for whom an address was available in 1998. The frequency of prognostic factors among those not contacted was very similar to those included in the study. The data were analysed using survival analysis by the nonparametric method of Kaplan Meier and the Cox regression model to determine risk ratios (RR) of prognostic factors. Survival rates were 42% at 1 year, 21% at 2 years, and 8% at 5 years after diagnosis. Patients aged 50-64 were found to have poorer survival compared with those less than 50 (RR = 1.73, P = 0.03); the risk ratio for ages f = 65 was 1.88 (P = 0.03). Females had significantly better survival than males (RR = 0.71, P = 0.02). For each 100 rads dose of radiotherapy, the risk ratio was significantly decreased by 1% (RR = 0.99, P = 0.05); for each session of radiotherapy, the risk ratio was significantly decreased by 4% (RR = 0.96, P = 0.0001); for each square centimetre size of surface under radiotherapy, the risk ratio significantly increased (RR = 1.002, P = 0.04). We did not observe a significant difference on survival by histology, anatomical location of tumours, or type of treatment (P > 0.05). Prognosis is extremely poor. (c) 2001 Cancer Research Campaign

Entities:  

Mesh:

Year:  2001        PMID: 11742486      PMCID: PMC2363975          DOI: 10.1054/bjoc.2001.2153

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Prognostic factors of esophageal carcinoma: univariate and multivariate analyses.

Authors:  K Sugimachi; H Matsuura; H Kai; T Kanematsu; K Inokuchi; K Jingu
Journal:  J Surg Oncol       Date:  1986-02       Impact factor: 3.454

2.  A clinico-pathological study of some factors influencing survival in cancer of the oesophagus: a survey of ten years' experience.

Authors:  R Nicks; D Green; G McClatchie
Journal:  Aust N Z J Surg       Date:  1973-07

3.  Patterns of recurrence after curative resection for carcinoma of the thoracic part of the esophagus.

Authors:  K Sugimachi; K Inokuchi; H Kuwano; H Kai; T Okamura; Y Okudaira
Journal:  Surg Gynecol Obstet       Date:  1983-12

4.  Carcinoma of the esophagus: results of treatment.

Authors:  J G van Andel; J Dees; C M Dijkhuis; W Fokkens; H van Houten; P C de Jong; W M van Woerkom-Eykenboom
Journal:  Ann Surg       Date:  1979-12       Impact factor: 12.969

5.  Analysis of factors influencing long-term survival after surgical resection for oesophageal squamous cell carcinoma.

Authors:  P Kolh; P Honore; J L Gielen; C Degauque; C Azzam; M Legrand; N Jacquet
Journal:  Acta Chir Belg       Date:  1999 May-Jun       Impact factor: 1.090

6.  Clinical evaluation of ten-year survival cases after operation for upper and mid-thoracic esophageal cancer.

Authors:  Y Kinoshita; M Endo; K Nakayama; H Sato; H Sato
Journal:  Int Surg       Date:  1982 Apr-Jun

7.  Treatment of carcinoma of the esophagus. Retrospective study of 2,400 patients.

Authors:  R Giuli; M Gignoux
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

Review 8.  Oesophageal squamous cell carcinoma: I. A critical review of surgery.

Authors:  R Earlam; J R Cunha-Melo
Journal:  Br J Surg       Date:  1980-06       Impact factor: 6.939

Review 9.  Oesophogeal squamous cell carcinoms: II. A critical view of radiotherapy.

Authors:  R Earlam; J R Cunha-Melo
Journal:  Br J Surg       Date:  1980-07       Impact factor: 6.939

10.  Cancer of the oesophagus. I. 1002 cases. Survey and survival.

Authors:  C Cederqvist; J Nielsen; A Berthelsen; H S Hansen
Journal:  Acta Chir Scand       Date:  1978
View more
  7 in total

1.  Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.

Authors:  Nazanin Saemi; Jalaleddin Khoshnevis; Mohammad Esmaeil Akbari; Alipasha Meysamie; Alireza Korourian; Barmak Gholizadeh; Leila Larijani; Afshin Moradi; Masoud Baikpour; Maryam Baikpour; Hanieh Zham
Journal:  J Gastrointest Cancer       Date:  2018-03

2.  Prognostic factors for esophageal squamous cell carcinoma--a population-based study in Golestan Province, Iran, a high incidence area.

Authors:  Karim Aghcheli; Haji-Amin Marjani; Dariush Nasrollahzadeh; Farhad Islami; Ramin Shakeri; Masoud Sotoudeh; Behnoush Abedi-Ardekani; Mohammad-Reza Ghavamnasiri; Ezzatollah Razaei; Elias Khalilipour; Samira Mohtashami; Yasha Makhdoomi; Rabea Rajabzadeh; Shahin Merat; Rasoul Sotoudehmanesh; Shahryar Semnani; Reza Malekzadeh
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

3.  Demographic and histological predictors of survival in patients with gastric and esophageal carcinoma.

Authors:  Yousef Veisani; Ali Delpisheh; Kourosh Sayehmiri; Ezzatollah Rahimi
Journal:  Iran Red Crescent Med J       Date:  2013-07-05       Impact factor: 0.611

4.  Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer.

Authors:  Jingjing Gao; Yumin Wu; Zhaoliang Su; Prince Amoah Barnie; Zhijun Jiao; Qingli Bie; Liwei Lu; Shengjun Wang; Huaxi Xu
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

Review 5.  Survival Rate of Esophageal Carcinoma in Iran - A Systematic Review and Meta-analysis.

Authors:  Amir Yarhusseini; Loghman Sharifzadeh; Ali Delpisheh; Yousef Veisani; Fatemeh Sayehmiri; Kourosh Sayehmiri
Journal:  Iran J Cancer Prev       Date:  2014

6.  Esophageal carcinoma: long-term survival in consecutive series of patients through a retrospective cohort study.

Authors:  Ali Delpisheh; Yousef Veisani; Kourosh Sayehmiri; Ezzatollah Rahimi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

7.  Survival of patients with stomach adenocarcinoma in North of Iran.

Authors:  Jamshid Yazdani-Charati; Ghasem Janbabaei; Siavosh Etemadinejad; Samaneh Sadeghi; Firoozeh Haghighi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.